Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment

OBJECTIVE: The treatment of patients with differentiated thyroid cancer (DTC) was modified in the last decade towards a more individualized approach according to the risk of recurrence (RR). We compared the outcomes of patients with low and intermediate RR (LRR and IRR) who received or did not recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Abelleira, Erika, Peñaloza, Mirna Angela, Jerkovich, Fernando, Bueno, Fernanda, Pitoia, Fabián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065346/
https://www.ncbi.nlm.nih.gov/pubmed/34731559
http://dx.doi.org/10.20945/2359-3997000000374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065346/
https://www.ncbi.nlm.nih.gov/pubmed/34731559
http://dx.doi.org/10.20945/2359-3997000000374

Ejemplares similares